Latest News, Updates & Breaking Headlines
A new experimental weight loss pill is giving hope to scientists that people may soon burn fat without losing precious muscle or fighting constant loss of appetite. Early human trials of the medication suggest it may offer an alternative to the current injectable medications that generally come with muscle loss and gut side effects. Double-edged…
Interest in therapies that support weight management has grown rapidly as new metabolic medicines reshape treatment choices and public expectations. Orforglipron, an oral GLP-1 receptor agonist, has become a key focus because it offers a tablet-based alternative to injectable options such as semaglutide and tirzepatide. Many individuals prefer oral medication for daily use, particularly when…
Influencers, podcast hosts and biohackers have hyped methylene blue online as a secret cognitive booster, fueling demand long before solid human evidence/ image, Instagram,X Videos of actors, podcasters and “biohackers” sipping or swallowing something bright blue have turned methylene blue into a minor wellness phenomenon. It is being described online as “brain fuel”, a “limitless…
If you’re a dog parent, you’ve probably had that moment: the day your energetic companion suddenly seems a little slower, a little quieter, or a little less eager to chase the ball they once lived for. Ageing creeps up on dogs quickly, especially larger breeds, and many owners end up asking the same hopeful question:…
High levels of low-density lipoprotein cholesterol (LDL-C) are a key risk factor for cardiovascular disease, which continues to be one of the leading causes of illness and death globally. LDL-C can accumulate in the walls of arteries over time, causing a condition known as atherosclerosis, in which the arteries become narrowed and blood flow is…
A new oral medication has shown LDL reductions of about 55.8%. The experimental drug, Enlicitide, developed by Merck, was presented at the American Heart Association Scientific Sessions 2025, and early results have excited cardiologists around the world.Unlike existing PCSK9 inhibitors, which require injections, Enlicitide is the first oral PCSK9 inhibitor, taken as a once-daily pill….
Cancer remains one of the leading causes of death worldwide, and in women, breast cancer is the most commonly diagnosed form. Its risk can be influenced by a range of factors including genetics, lifestyle, obesity, delayed childbirth, and prolonged hormone exposure. Over the past few decades, doctors have observed a steady rise in breast cancer…
In a moment of panic after contraceptive slip or unprotected sex, morning after pill is considered to be one of the most effective ways to prevent unintended pregnancy. However, morning-after pills can also bring some changes to the body. What is the morning-after pill These are emergency contraceptives, used as a backup to prevent pregnancy….
The U.S. Food and Drug Administration (FDA) has made a major move in heart health care by approving Rybelsus, the first oral GLP-1 receptor agonist, which helps to manage cardiovascular risks. Up until now, Rybelsus was known as a diabetes medication and was only taken in cases of increased blood sugar levels, in adults with…
Over 140,000 bottles of Ascend Laboratories’ Atorvastatin Calcium Tablets, a cholesterol medication, have been recalled due to ‘failed dissolution specifications.’ This means the drug may not be absorbed by the body. The recall, classified as Class II, affects various dosages and bottle sizes distributed globally. No illnesses have been reported. Over 140,000 bottles of a…
